Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • noatz
    Junior Member
    • Feb 2012
    • 1

    #1

    Cuffdiff 2.1.1 normalization

    Hi,
    I used cuffdiff 2.1.1 with the default geometric normalization, which should not consider the transcripts' length but only the geometric mean of number of counts per sample (as DESeq does).
    If this is so, I don't understand the meaning of 2 other optional parameters:

    --no-effective-length-correction: "Cufflinks will not employ its "effective" length normalization to transcript FPKM"
    and
    --no-length-correction: "Cufflinks will not normalize fragment counts by transcript length at all (??). Use this option when fragment count is independent of the size of the features being quantified (e.g. for small RNA libraries, where no fragmentation takes place, or 3 prime end sequencing, where sampled RNA fragments are all essentially the same length). Experimental option, use with caution".

    Can anyone tell the difference between these 2 options, and why are they needed if the geometric mean normalization does not consider the length anyway?
    Thanks
    Noa

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 08-13-2026, 12:22 PM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-11-2026, 10:35 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
38 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
51 views
0 reactions
Last Post SEQadmin2  
Working...